Scoring System of Structural Damage for the Hip in Juvenile Idiopathic Arthritis

N/AUnknownNCT05206968

University Tunis El Manar45 enrolled

Overview

Juvenile idiopathic arthritis (JIA) is a chronic inflammatory disease in children affecting mobility and physical function. The hip involvement represents a frequent complication in JIA patients. The assessment of hip damage becomes a mandatory step in disease monitoring. However, radiological scoring was not standardized. This study aimed to compare the two scoring systems previously proposed, examine their repeatability and their intra and inter agreement.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Juvenile Idiopathic Arthritis Hip

Interventions

pelvic radiographRADIATION

Patients with hip involvement underwent a pelvic radiograph

Eligibility

Sex: ALLMin age: 4 YearsMax age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All included patient followed the ILAR criteria of JIA and have a hip involvement. This later was defined as the presence of rang motion limitation, and abnormal findings in pelvic radiographic, or ultrasound or MRI in the coxo-femoral joint. Exclusion Criteria: * The presence of a contraindication to the performance of conventional radiography any disease affecting cognition Patients who have had surgery on the hip

Locations (1)

Kassab institute of orthopedics

Manouba, Tunisia

RECRUITING

Outcomes

Primary Outcomes

intermodality agreement

mesuring the intermodality agreement between two scoring system: the The Childhood Arthritis Radiographic Score of the Hip (CARSH) and the new radiographic scoring system for growth abnormalities and structural change in children with juvenile idiopathic arthritis of the hip

Time frame: 6 months

Secondary Outcomes

interreader agreement

mesuring the interreader agreement between two experimented pediatric rheumatologist for the assessement of structurla damage in JIA hip

Time frame: 3 months

Central Contacts

Hanène Lassoued Ferjani, assistant professor

CONTACT

97950842 lassouedferjanihanene@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.